On this page
tregzi
allogeneic regulatory T cell immunotherapy with HSPC and T cells-vldq
351(a) Standalone BLA
Overview
Source: Purple BookProprietary name
tregzi
Proper name
allogeneic regulatory T cell immunotherapy with HSPC and T cells-vldq
Licence type
351(a)
BLA number
125868
Applicant
Orca Biosystems Inc.
Center
CBER
Presentations
1
First licensure
—
Presentations
Source: Purple Book| Strength | Dosage form | Route | Presentation | Status | Licensed |
|---|---|---|---|---|---|
| >=1.0 10^6HSPC CELLS,0.9-3.510^6 TREG CELLS,0.9-6.910^6 TCON CELLS /PATIENT KG | Solution | Intravenous | Bag | Rx | June 30, 2026 |
Sources for this page
| Purple Book | FDA | Licence type, presentations, reference product, exclusivity |